Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02091011 · ClinicalTrials.gov registry record
LONGEVITY Study. Evaluation of the Device and Battery Longevity of Boston Scientific Market-released ICD and CRT-D Devices
A clinical trial, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 1,600
- Enrollment target
NCT02091011 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 1,600 participants.
The verdict
NCT02091011 has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 1,600 participants
- Enrollment target
Study Summary
The study is to determine the rate and cause of device replacements at 5 years post-implantation. It will assess the battery and device longevity of the Implantable Cardioverter Defibrillators (ICD) and CRT-D Cardiac Resynchronization Therapy Defibrillator (CRT-D) devices. It will also validate the device survival information given in Boston Scientific's Product Performance Report by comparing the pulse generator (PG) survival probability in the study to that presented in the Product Performance Reports (PPR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,600 participants |
| Start Date | 2014-01-27 |
| Est. Completion | 2021-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02091011
The ClinicalTrials.gov registry entry for NCT02091011 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02091011 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02091011 about?
NCT02091011 is a clinical study titled "LONGEVITY Study. Evaluation of the Device and Battery Longevity of Boston Scientific Market-released ICD and CRT-D Devices". The study is to determine the rate and cause of device replacements at 5 years post-implantation. It will assess the battery and device longevity of the Implantable Cardioverter Defibrillators (ICD) and CRT-D Cardiac Resynchronization Therapy Defibrillator (CRT-D) devices. It will also validate the ...
What is the current status of trial NCT02091011?
This trial is currently completed. The enrollment target is 1,600 participants. The study started on 2014-01-27. Estimated completion is 2021-08.
Who is sponsoring clinical trial NCT02091011?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.